Ivana Stojanovic

7PUBLICATIONS
34CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Hypersonic propulsion and hypersonic aerothermodynamicsRegenerative medicine (incl. stem cells)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 04, 2026
FFAR2 activation induces IL-22-dependent intestinal immune responses to suppress CNS autoimmunity.

|May 18, 2026
Activation of Intestinal Type 3 Innate Lymphoid Cells and Regulatory T Cells Through Free Fatty Acid Receptor 2 Ameliorates Type 1 Diabetes in Mice.

|Jul 13, 2024
Development of FluoAHRL: A Novel Synthetic Fluorescent Compound That Activates AHR and Potentiates Anti-Inflammatory T Regulatory Cells.

Natalija Jonić, Ivan Koprivica, Christos M Chatzigiannis

|Jun 19, 2024
Mesenchymal Stem Cells from Mouse Hair Follicles Inhibit the Development of Type 1 Diabetes.

Dragica Mićanović, Suzana Stanisavljević, Hanluo Li

|Apr 28, 2023
Development of Type 1 Diabetes in Mice Is Associated with a Decrease in IL-2-Producing ILC3 and FoxP3+ Treg in the Small Intestine.

Tamara Saksida, Verica Paunović, Ivan Koprivica

|Aug 19, 2020
Immunomodulatory activity and protective effects of chokeberry fruit extract on Listeria monocytogenes infection in mice.

Dragica Gajić, Tamara Saksida, Ivan Koprivica

Pageof 2

Frequent Collaborators

4 joint publications

Dragica Mićanović

3 joint publications

Natalija Jonić

2 joint publications

Tamara Saksida

2 joint publications

Ivan Koprivica